Table 4.
End Point | Covariate | Coefficien | Hazard ratio | 95% CI | p-value |
---|---|---|---|---|---|
Recurrence under immediate RP | Age | 0.01 | 1.01 | (0.98, 1.03) | 0.527 |
(Fit to low-risk CaPSURE cohort) | PSA | 0.15 | 1.16 | (1.07, 1.25) | < 0.001 |
| |||||
Recurrence under delayed RP | Age | 0.01 | 1.01 | (1.00, 1.03) | 0.187 |
(Fit to T-stage ≤ T2a CaPSURE cohort) | PSA | 0.03 | 1.03 | (1.02, 1.03) | < 0.001 |
Gleason score | |||||
≤ 6 | ref | ||||
7 | 0.47 | 1.59 | (1.25, 2.03) | < 0.001 | |
≥ 8 | 1.43 | 4.16 | (2.92, 5.93) | < 0.001 | |
| |||||
Prostate cancer mortality | Time to recurrence | −0.44 | 0.65 | (0.51, 0.82) | < 0.001 |
Gleason score | |||||
≤ 6 | ref | ||||
7 | 0.56 | 1.75 | (0.96, 3.17) | 0.066 | |
≥ 8 | 0.89 | 2.43 | (1.21, 4.86) | 0.012 |